0

    539428

    TEJNAKSH

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Tejnaksh Healthcare Limited Share Price Today

    Investment Returns

    Over 1 Month -11.53% Over 3 Months -16.68% Over 6 Months -14.70% Over 1 Year -32.70%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Tejnaksh Healthcare Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 26.20
    • P/E Ratio (TTM) 18.94
    • Beta 0.59
    • Book Value / share 13.19
    • Return on equity 10.87%
    • EPS (TTM) 0.68
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.50
    info icon alternate text

    Tejnaksh Healthcare Limited Financials

    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 1.77
    Operating Expense 1.31
    Net Profit 0.50
    Net Profit Margin (%) 28.24
    Earnings Per Share (EPS) 0.39
    EBITDA 0.96
    Effective Tax Rate (%) 17.74
    Particulars DEC 2025 (Values in Cr)
    Revenue 1.69
    Operating Expense 1.46
    Net Profit 0.23
    Net Profit Margin (%) 13.60
    Earnings Per Share (EPS) 0.11
    EBITDA 0.66
    Effective Tax Rate (%) 23.33
    Particulars SEP 2025 (Values in Cr)
    Revenue 1.94
    Operating Expense 1.59
    Net Profit 0.31
    Net Profit Margin (%) 15.97
    Earnings Per Share (EPS) 0.15
    EBITDA 0.79
    Effective Tax Rate (%) 26.19
    Particulars JUN 2025 (Values in Cr)
    Revenue 1.78
    Operating Expense 1.41
    Net Profit 0.34
    Net Profit Margin (%) 19.10
    Earnings Per Share (EPS) 0.17
    EBITDA 0.82
    Effective Tax Rate (%) 24.44
    Particulars MAR 2025 (Values in Cr)
    Revenue 2.40
    Operating Expense 1.43
    Net Profit 0.75
    Net Profit Margin (%) 31.25
    Earnings Per Share (EPS) 0.37
    EBITDA 1.23
    Effective Tax Rate (%) 26.92
    Particulars MAR 2026 (Values in Cr)
    Revenue 7.17
    Operating Expense 5.76
    Net Profit 1.38
    Net Profit Margin (%) 19.24
    Earnings Per Share (EPS) 0.68
    EBITDA 3.23
    Effective Tax Rate (%) 22.90
    Particulars MAR 2025 (Values in Cr)
    Revenue 8.80
    Operating Expense 5.49
    Net Profit 2.62
    Net Profit Margin (%) 29.77
    Earnings Per Share (EPS) 1.29
    EBITDA 4.83
    Effective Tax Rate (%) 28.41
    Particulars MAR 2024 (Values in Cr)
    Revenue 8.22
    Operating Expense 6.07
    Net Profit 1.81
    Net Profit Margin (%) 22.01
    Earnings Per Share (EPS) 0.89
    EBITDA 3.92
    Effective Tax Rate (%) 25.51
    Particulars MAR 2023 (Values in Cr)
    Revenue 7.34
    Operating Expense 5.60
    Net Profit 1.38
    Net Profit Margin (%) 18.80
    Earnings Per Share (EPS) 0.68
    EBITDA 3.36
    Effective Tax Rate (%) 29.59
    Particulars MAR 2022 (Values in Cr)
    Revenue 8.12
    Operating Expense 4.88
    Net Profit 2.52
    Net Profit Margin (%) 31.03
    Earnings Per Share (EPS) 2.48
    EBITDA 4.43
    Effective Tax Rate (%) 25.22
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 12.76
    ROE % 9.01
    ROCE % 12.77
    Total Debt to Total Equity 0.12
    EBITDA Margin 34.88
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 11.60
    ROE % 7.76
    ROCE % 10.64
    Total Debt to Total Equity 0.25
    EBITDA Margin 32.35
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 21.43
    ROE % 8.56
    ROCE % 11.24
    Total Debt to Total Equity 0.32
    EBITDA Margin 34.19
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 19.75
    ROE % 15.03
    ROCE % 17.08
    Total Debt to Total Equity 0.32
    EBITDA Margin 38.72
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 17.05
    ROE % 12.71
    ROCE % 14.10
    Total Debt to Total Equity 0.37
    EBITDA Margin 32.19
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 12.51
    ROE % 10.87
    ROCE % 14.64
    Total Debt to Total Equity 0.12
    EBITDA Margin 55.00
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 11.21
    ROE % 8.28
    ROCE % 11.12
    Total Debt to Total Equity 0.26
    EBITDA Margin 47.81
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 20.62
    ROE % 6.81
    ROCE % 9.41
    Total Debt to Total Equity 0.33
    EBITDA Margin 45.91
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 19.25
    ROE % 13.77
    ROCE % 15.63
    Total Debt to Total Equity 0.33
    EBITDA Margin 54.68
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 16.76
    ROE % 12.48
    ROCE % 13.82
    Total Debt to Total Equity 0.38
    EBITDA Margin 43.69
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.79
    Total Assets 30.30
    Total Liabilities 30.30
    Total Equity 26.45
    Share Outstanding 2
    Price to Book Ratio 1.68
    Return on Assets (%) 7.68
    Return on Capital (%) 8.59
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 4.25
    Total Assets 31.35
    Total Liabilities 31.35
    Total Equity 24.20
    Share Outstanding 2
    Price to Book Ratio 2.07
    Return on Assets (%) 5.66
    Return on Capital (%) 6.27
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.13
    Total Assets 31.22
    Total Liabilities 31.22
    Total Equity 22.41
    Share Outstanding 1
    Price to Book Ratio 3.34
    Return on Assets (%) 5.38
    Return on Capital (%) 5.95
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 3.00
    Total Assets 29.60
    Total Liabilities 29.60
    Total Equity 20.59
    Share Outstanding 1
    Price to Book Ratio 8.75
    Return on Assets (%) 9.19
    Return on Capital (%) 10.13
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.23
    Total Assets 24.57
    Total Liabilities 24.57
    Total Equity 17.76
    Share Outstanding 1
    Price to Book Ratio 4.34
    Return on Assets (%) 8.35
    Return on Capital (%) 9.35
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.64
    Total Assets 29.00
    Total Liabilities 29.00
    Total Equity 25.40
    Share Outstanding 2
    Price to Book Ratio 1.68
    Return on Assets (%) 9.03
    Return on Capital (%) 10.07
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 3.94
    Total Assets 30.11
    Total Liabilities 30.11
    Total Equity 22.77
    Share Outstanding 2
    Price to Book Ratio 2.07
    Return on Assets (%) 6.01
    Return on Capital (%) 6.74
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 2.47
    Total Assets 29.80
    Total Liabilities 29.80
    Total Equity 20.94
    Share Outstanding 1
    Price to Book Ratio 3.34
    Return on Assets (%) 4.62
    Return on Capital (%) 5.13
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.43
    Total Assets 28.67
    Total Liabilities 28.67
    Total Equity 19.55
    Share Outstanding 1
    Price to Book Ratio 8.75
    Return on Assets (%) 8.78
    Return on Capital (%) 9.73
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.56
    Total Assets 23.87
    Total Liabilities 23.87
    Total Equity 17.02
    Share Outstanding 1
    Price to Book Ratio 4.34
    Return on Assets (%) 8.39
    Return on Capital (%) 9.43
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.19
    Cash from Operations 0.85
    Cash from Investing 3.52
    Cash from Financing -3.86
    Net change in Cash 0.03
    Free Cash Flow 1.10
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.37
    Cash from Operations 4.34
    Cash from Investing -1.01
    Cash from Financing -2.26
    Net change in Cash 0.72
    Free Cash Flow 5.04
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.51
    Cash from Operations 1.70
    Cash from Investing -1.40
    Cash from Financing -1.19
    Net change in Cash -0.47
    Free Cash Flow 2.52
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.76
    Cash from Operations 8.96
    Cash from Investing -10.58
    Cash from Financing 1.61
    Net change in Cash 0.23
    Free Cash Flow 18.04
    Particulars MAR 2021 (Values in Cr)
    Net Income 2.66
    Cash from Operations 0.47
    Cash from Investing 1.55
    Cash from Financing -2.80
    Net change in Cash -0.06
    Free Cash Flow 0.91
    Particulars MAR 2025 (Values in Cr)
    Net Income 3.66
    Cash from Operations 0.97
    Cash from Investing 3.57
    Cash from Financing -3.86
    Net change in Cash 0.19
    Free Cash Flow 1.16
    Particulars MAR 2024 (Values in Cr)
    Net Income 2.43
    Cash from Operations 4.47
    Cash from Investing -1.07
    Cash from Financing -2.31
    Net change in Cash 0.75
    Free Cash Flow 4.90
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.96
    Cash from Operations 1.51
    Cash from Investing -0.98
    Cash from Financing -1.17
    Net change in Cash -0.25
    Free Cash Flow 2.20
    Particulars MAR 2022 (Values in Cr)
    Net Income 3.37
    Cash from Operations 8.88
    Cash from Investing -10.39
    Cash from Financing 1.61
    Net change in Cash 0.34
    Free Cash Flow 17.74
    Particulars MAR 2021 (Values in Cr)
    Net Income 2.59
    Cash from Operations 0.34
    Cash from Investing 1.55
    Cash from Financing -2.86
    Net change in Cash -0.46
    Free Cash Flow 0.78
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8980.50 69.09 13.62 129125.81 6680.00 9326.80
    FORTIS MALAR HOSPITALS LIMITED 49.16 0.00 2.68 92.13 40.75 76.00
    SHREE PACETRONIX LTD. 147.00 17.54 3.09 55.12 90.00 283.15
    TRANSGENE BIOTEK LTD. 2.91 0.00 2.63 22.05 1.83 5.17
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    APOLLO HOSPITALS ENTER. L 8980.50 91.79 12.96 129125.81 6680.00 9326.80
    [-] 0.0 0.0 0.0 0.0 0.0 0.0
    CHENNAI MEENAKSHI MULTISPECIAL 38.95 0.00 -9.47 29.10 30.30 57.48
    KOVAI MEDICAL CENTER & HO 5847.45 25.99 4.84 6397.11 5010.00 6725.00

    Tejnaksh Healthcare Limited shareholding pattern

    Holding
    26.16%
    73.83%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    Tejnaksh Healthcare Limited Technicals Summary

    12.88 -2.12 redarrow
    red-green-graph indicator
    16 Bearish
    0 Bullish
    • 5 Days 13.30
    • 26 Days 14.00
    • 10 Days 13.60
    • 50 Days 14.20
    • 12 Days 13.60
    • 100 Days 14.50
    • 20 Days 13.80
    • 200 Days 15.50
    12.92 PIVOT
    First Support 12.29 First Resistance 13.79 Second Support 11.42 Second Resistance 14.42 Third Support 10.79 Third Resistance 15.29
    RSI 35.96 ADX 12.23 MACD -0.34 Williams % R -68.08 Commodity Channel Index (CCI) -212.50
    Date 2026-08-07 Week 10158.00 Same Day 4438.00 Month 5035.00
    1 Year 0.60 3 Year 0.58
    Over 1 Month
    -11.53% down
    Over 1 Year
    -32.70% down
    Over 3 Months
    -16.68% down
    Over 3 Years
    -28.33% down
    Over 6 Months
    -14.70% down
    Over 5 Years
    -23.34% down

    Tejnaksh Healthcare Limited Corporate Actions

    Ex-Date Ex-Bonus Ratio
    28 Apr 2018 26 Apr 2018 36:10
    09 Mar 2017 08 Mar 2017 1:1
    Ex-Date Old FV NEW FV Record Date
    19 Jul 2023 10.0 5.0 19 Jul 2023

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Tejnaksh Healthcare Ltd?

    Answer Field

    Tejnaksh Healthcare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 12.88 as on Aug 07 2026 03:27 PM.

    What is the Market Cap of Tejnaksh Healthcare Ltd Share?

    Answer Field

    The market cap of Tejnaksh Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 26.20 as on Aug 07 2026 03:27 PM.

    What is the 52 Week High and Low of Tejnaksh Healthcare Ltd?

    Answer Field

    The 52 Week High and Low of Tejnaksh Healthcare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 19.89 and ₹ 10.65.

    What is 1 year return for Tejnaksh Healthcare Ltd?

    Answer Field

    The 1 year returns on the stock has been -32.70%.

    What is the P/E Ratio of Tejnaksh Healthcare Ltd Share?

    Answer Field

    As on Aug 07 2026 03:27 PM the price-to-earnings (PE) ratio for Tejnaksh Healthcare Ltd share is 18.94.

    What is the PB ratio of Tejnaksh Healthcare Ltd Share?

    Answer Field

    As on Aug 07 2026 03:27 PM, the price-to-book (PB) ratio for Tejnaksh Healthcare Ltd share is 13.19.

    How to Buy Tejnaksh Healthcare Ltd Share?

    Answer Field

    You can trade in Tejnaksh Healthcare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Tejnaksh Healthcare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Tejnaksh Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Tejnaksh Healthcare Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |